| Name | Title | Contact Details |
|---|
Besafemeds takes today`s technology and applies it to healthcare to deliver a discreet treatment option for STDs. We store no identifiable data on our users. Once a determination is made that a prescription is needed and subsequently transmitted to the pharmacy of your choice, all identifiable data is purged from the system. Besafemeds is staffed by physicians and nurse practitioners following standard treatment guidelines for the two most common STDs (gonorrhea and chlamydia). In an ideal world, testing should occur before treatment. However, besafemeds is here for those who need or want a discreet and quick STD treatment option.
UCG is the foremost company in the industry, offering a full platform of cannabis manufacturing services guiding clients from the ground up.
Flashpoint-Diccicco Battista Communications is a Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
March 6, 2006 - As the Hunt Memorial Hospital District continues to develop the final plans for the new Cancer Center, Presbyterian Hospital of Greenville is keeping sight of the softer side of patient care.